Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 08/25 10:03:35 pm
95.875 EUR   -0.87%
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/22 BAYER : Not intended for U.S. and UK Media -- New Real-World Evidenc..
08/17 BAYER : and the Canadian Vascular Network (CVN) Announce the 2016 Re..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : Bayer CropScience Expands Research and Development Cooperation with Nature Source Genetics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/14/2013 | 03:33pm CEST

Bayer%20CropScience%20Expands%20Research%20and%20Development%20Cooperation%20with%20Nature%20Source%20Genetics%20');openNewWindow('../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download',500,525,0,0,'scrollbars=yes,resizable=yes,statusbar=no');return false;" href="../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download" sizset="false" sizcache02840271716677351="0.0.10"downloadSoybean plants

Monheim (Germany) and Ithaca (USA), March 14, 2013- Bayer CropScience and the research company Nature Source Genetics, based in Ithaca, New York, USA, have signed an agreement to expand their already fruitful cooperation. They have entered into a five-year collaboration involving the pre-breeding and enhancement of soybean germplasm. The goal is to create improved seed by making use of innovative technologies to identify and incorporate previously non detectable, naturally occurring genes. Financial terms have not been disclosed.

The partnership will combine the expertise of Bayer CropScience's soybean breeders and geneticists with Nature Source Genetics' technical know-how and the company's bioanalytical platform to identify and utilize the full range of promising germplasm. The partnership also builds on a successful cotton partnership, which began in 2008.

"The collaboration between Bayer CropScience and Nature Source Genetics marks a significant expansion in the strategic scope of our soybean breeding program", said Mike Gilbert, Head of Global Breeding and Trait Development at Bayer CropScience. "With this partnership, we now have access to new and valuable sources of genetic diversity in soybeans, which we can incorporate into our already robust breeding program to further expand and improve the products we offer growers worldwide."

This agreement will provide Bayer CropScience researchers with the opportunity to identify high value genes in previously unused genetic material and incorporate these new genes into commercial germplasm.

"We are very pleased to be entering into this joint venture with Bayer CropScience for the genetic improvement of soy. Nature Source Genetics brings to this partnership unique expertise and proprietary algorithms developed within its bioanalytical platform encompassing diverse competencies from life and computational sciences," said Professor Steven D. Tanksley, CEO and Chief Scientific Officer of Nature Source Genetics. "These competencies will significantly expedite the identification and incorporation of new and useful genetic variation into Bayer CropScience's breeding material for the development of improved commercial varieties."

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission "Bayer: Science For A Better Life". Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world's leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

About Nature Source Genetics
Nature Source Genetics is a company based in Ithaca, New York co-founded in 2006 by Professor Steven D. Tanksley and Dr. Theresa M. Fulton from Cornell University with Dr. Vincent Pétiard, the former Head of Plant Sciences and Technology at Nestlé. Nature Source Genetics offers exclusive services on a crop per crop basis, and is currently working on different field crops, vegetables, and tropical crops with agro-seed and food companies to optimize the benefits of natural genetic diversity in target crops. Nature Source Genetics has also started to explore with animal breeding companies the opportunities of use of its computational genomics capabilities. More info at: www.naturesourcegenetics.com

Find more information at www.bayercropscience.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/22 COVESTRO : Assigned Patent
08/22 BAYER : Not intended for U.S. and UK Media -- New Real-World Evidence on Venous ..
08/18 BAYER CROPSCIENCE : Research Conducted at Bayer CropScience Has Provided New Inf..
08/17 BAYER : and the Canadian Vascular Network (CVN) Announce the 2016 Research Fello..
08/15 Covestro LLC Receives US2020's 2016 STEM Mentoring Award for 'Excellence in C..
08/12 COVESTRO : Longer lives, greater financial needs lead to delayed retirements
08/11DJEU Opens Antitrust Probe on Dow Chemical-DuPont Merger
08/11 Covestro LLC Receives US2020's 2016 STEM Mentoring Award for 'Excellence in C..
08/05 BAYER : reported to be reviewing Monsanto's books as it mulls higher bid
More news
Sector news : Pharmaceuticals - NEC
05:46p FTSE retreats as pharma stocks fall
03:56pDJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
03:12pDJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
03:11pDJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3rd Update
02:15pDJMylan Boosts Price Assistance for EpiPen Amid Backlash
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/23 Who's Next After Medivation?
08/23 Apple Wants You To Feel Better
08/23 BLOOMBERG : Bayer, Monsanto moving closer to deal
08/22 Berkshire Boosts Apple Stake And Other Moves From Top Managers
08/19 Bayer/CRISPR Therapeutics joint venture Casebia Therapeutics establishes oper..
Advertisement
Financials (€)
Sales 2016 46 964 M
EBIT 2016 8 224 M
Net income 2016 4 747 M
Debt 2016 15 954 M
Yield 2016 2,77%
P/E ratio 2016 17,62
P/E ratio 2017 14,95
EV / Sales 2016 2,04x
EV / Sales 2017 1,89x
Capitalization 79 982 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 109 €
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-16.48%90 173
JOHNSON & JOHNSON15.57%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.45%213 882
PFIZER INC.7.87%211 206
MERCK & CO., INC.18.76%173 462
More Results